Edwards C - Search Results

1

Afamelanotide for Erythropoietic Protoporphyria.

Langendonk JG, Balwani M, Anderson KE, Bonkovsky HL, Anstey AV, Bissell DM, Bloomer J, Edwards C, Neumann NJ, Parker C, Phillips JD, Lim HW, Hamzavi I, Deybach JC, Kauppinen R, Rhodes LE, Frank J, Murphy GM, Karstens FPJ, Sijbrands EJG, de Rooij FWM, Lebwohl M, Naik H, Goding CR, Wilson JHP, Desnick RJ. Langendonk JG, et al. Among authors: edwards c. N Engl J Med. 2015 Jul 2;373(1):48-59. doi: 10.1056/NEJMoa1411481. N Engl J Med. 2015. PMID: 26132941 Free PMC article. Clinical Trial.

2

Therapeutic ultraviolet light-emitting diode sources: a new phase in the evolution of phototherapy.

Edwards C, Anstey AV. Edwards C, et al. Br J Dermatol. 2010 Jul;163(1):3-4. doi: 10.1111/j.1365-2133.2010.09870.x. Br J Dermatol. 2010. PMID: 20645980 No abstract available.

3

Home phototherapy for psoriasis: a review and update.

Hung R, Ungureanu S, Edwards C, Gambles B, Anstey AV. Hung R, et al. Among authors: edwards c. Clin Exp Dermatol. 2015 Dec;40(8):827-2; quiz 832-3. doi: 10.1111/ced.12703. Epub 2015 Oct 12. Clin Exp Dermatol. 2015. PMID: 26456768 Review.

4

Validation of a semiautomated method of minimal erythema dose testing for narrowband ultraviolet B phototherapy.

Otman SG, Edwards C, Gambles B, Anstey AV. Otman SG, et al. Among authors: edwards c. Br J Dermatol. 2006 Aug;155(2):416-21. doi: 10.1111/j.1365-2133.2006.07273.x. Br J Dermatol. 2006. PMID: 16882183

5

Targeted ultraviolet B phototherapy: definition, clinical indications and limitations.

Alshiyab D, Edwards C, Chin MF, Anstey AV. Alshiyab D, et al. Among authors: edwards c. Clin Exp Dermatol. 2015 Jan;40(1):1-5. doi: 10.1111/ced.12441. Clin Exp Dermatol. 2015. PMID: 25495672 Review.

6

Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.

Al-Ismail D, Edwards C, Anstey AV. Al-Ismail D, et al. Among authors: edwards c. Br J Dermatol. 2016 Jan;174(1):131-5. doi: 10.1111/bjd.14101. Epub 2015 Nov 14. Br J Dermatol. 2016. PMID: 26383592 Clinical Trial.

7

Modulation of ultraviolet (UV) transmission by emollients: relevance to narrowband UVB phototherapy and psoralen plus UVA photochemotherapy.

Otman SG, Edwards C, Pearse AD, Gambles BJ, Anstey AV. Otman SG, et al. Among authors: edwards c. Br J Dermatol. 2006 May;154(5):963-8. doi: 10.1111/j.1365-2133.2006.07171.x. Br J Dermatol. 2006. PMID: 16634902

8

Minimal phototoxic dose (MPD) measurements for topical photochemotherapy using a semiautomated MPD tester.

Al-Ismail D, Edwards C, Al-Ofi O, Anstey AV. Al-Ismail D, et al. Among authors: edwards c. Br J Dermatol. 2013 Sep;169(3):687-9. doi: 10.1111/bjd.12395. Br J Dermatol. 2013. PMID: 23607709 Clinical Trial.

9

An evaluation of the preferences of patients with psoriasis between systemic psoralen plus ultraviolet A and bath psoralen plus ultraviolet A.

Alshiyab D, Chin MF, Edwards C, Anstey AV. Alshiyab D, et al. Among authors: edwards c. Br J Dermatol. 2015;172(5):1457-8. doi: 10.1111/bjd.13561. Epub 2015 Mar 27. Br J Dermatol. 2015. PMID: 25420468 No abstract available.

10

Rate of acute adverse events for narrow-band UVB and Psoralen-UVA phototherapy.

Martin JA, Laube S, Edwards C, Gambles B, Anstey AV. Martin JA, et al. Among authors: edwards c. Photodermatol Photoimmunol Photomed. 2007 Apr-Jun;23(2-3):68-72. doi: 10.1111/j.1600-0781.2007.00278.x. Photodermatol Photoimmunol Photomed. 2007. PMID: 17523927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,827 results

Search Page